Carnegie downgrades Yubico to hold (buy), with a target price of 270 SEK (300)
Barclays upgrades Mercedes-Benz Group to equal weight (underweight), target price 57.50 euros
RBC downgrades Gea Group to sector perform (outperform), target price 52 euros
RBC downgrades Nestle to sector perform (outperform), target price 93 Swiss francs
Morgan Stanley upgrades Zealand Pharma to overweight (equal weight), target price 750 Danish kroner
RBC lowers the target price for Atlas Copco to 140 SEK (150), reiterates underperform
RBC raises the target price for Sandvik to 270 SEK (250), reiterates outperform
Jefferies lowers the target price for Essity to 279 SEK (284), reiterates hold
SEB raises the target price for OEM International to 160 SEK (146), reiterates buy
Barclays downgrades Rockwool to equal weight (overweight), target price 3,300 Danish kroner
JP Morgan upgrades Tele2 to overweight (neutral), target price 156 SEK
Pareto Securities lowers the target price for Sedana Medical to 20 SEK (25), reiterates buy
Pareto Securities downgrades Lime to hold (buy), target price 400 SEK (410)
Carnegie lowers the target price for Novo Nordisk to 910 Danish kroner (1,024), reiterates buy
In the world of finance, stock recommendations and target prices play a crucial role in guiding investors’ decisions. Analysts at top firms like Carnegie, Barclays, RBC, Morgan Stanley, Jefferies, SEB, JP Morgan, and Pareto Securities are constantly evaluating companies and issuing updates on their stock ratings and price targets.
Recently, Carnegie downgraded Yubico to a hold rating from a buy, with a target price of 270 SEK, a slight decrease from the previous target of 300 SEK. This decision reflects a shift in the firm’s outlook on Yubico’s performance and potential in the market. Meanwhile, Barclays upgraded Mercedes-Benz Group to equal weight from underweight, setting a target price of 57.50 euros. This upgrade indicates a more positive view on the company’s prospects moving forward.
On the other hand, RBC made some notable changes to its recommendations, downgrading Gea Group to sector perform from outperform, with a target price of 52 euros. The firm also downgraded Nestle to sector perform from outperform, with a target price of 93 Swiss francs. These adjustments reflect RBC’s assessment of the companies’ abilities to outperform in the current market conditions.
Morgan Stanley took a different approach by upgrading Zealand Pharma to overweight from equal weight, with a target price of 750 Danish kroner. This upgrade suggests a bullish outlook on Zealand Pharma’s growth potential. RBC also made changes to its target prices, lowering Atlas Copco’s target to 140 SEK from 150 SEK, while raising Sandvik’s target to 270 SEK from 250 SEK. These adjustments indicate RBC’s updated expectations for the companies’ stock performance.
Jefferies revised its target price for Essity, lowering it to 279 SEK from 284 SEK, but maintaining a hold rating. SEB, on the other hand, raised its target price for OEM International to 160 SEK from 146 SEK, reiterating a buy recommendation. Barclays downgraded Rockwool to equal weight from overweight, with a target price of 3,300 Danish kroner, signaling a more neutral stance on the company’s stock.
JP Morgan upgraded Tele2 to overweight from neutral, with a target price of 156 SEK, reflecting a more positive outlook on the company’s performance. Pareto Securities made adjustments to its target prices as well, lowering Sedana Medical’s target to 20 SEK from 25 SEK, while downgrading Lime to hold from buy, with a target price of 400 SEK, down from 410 SEK.
In a final update, Carnegie lowered the target price for Novo Nordisk to 910 Danish kroner from 1,024 Danish kroner, while reiterating a buy recommendation. These changes in stock ratings and target prices provide valuable insights for investors looking to make informed decisions in the market.